Latest news
Loading news…
Genuone Sciences
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Seoul, Seoul-t'ukpyolsi, South Korea Founded 2020 501-1000 employees For Profit
Genuone Sciences is a CDMO pharmaceutical company that improves the performance of existing pharmaceutical medicines.
Genuone Sciences was acquired by Macquarie Asset Management in 2024 for $449M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2020
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 1
- HQ
- Seoul, Seoul-t'ukpyolsi, South Korea
- Region
- Asia-Pacific (APAC)
- Exit date
- May 1, 2024
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -1
- Trend (90d)
- -0.6
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Genuone Sciences
Loading news…
FAQs about Genuone Sciences
People who checked this page also checked these
Browse the full Acquirezy directory.